Loading clinical trials...
Loading clinical trials...
Phase II Study of P1101 in Early Myelofibrosis
Conditions
Interventions
Laboratory Biomarker Analysis
Quality-of-Life Assessment
+1 more
Locations
1
United States
Mayo Clinic in Arizona
Scottsdale, Arizona, United States
Start Date
August 12, 2015
Primary Completion Date
November 30, 2023
Completion Date
November 30, 2023
Last Updated
October 27, 2025
NCT07357727
NCT06976918
NCT06343805
NCT06327100
NCT06361641
NCT04279847
Lead Sponsor
Mayo Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions